These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36413993)

  • 1. Prevalence of benign focal liver lesions and non-hepatocellular carcinoma malignant lesions in liver cirrhosis.
    Möller K; Safai Zadeh E; Görg C; Dong Y; Cui XW; Faiss S; Dietrich CF
    Z Gastroenterol; 2023 May; 61(5):526-535. PubMed ID: 36413993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence and significance of small focal liver lesions in MRI].
    Kreft B; Pauleit D; Bachmann R; Conrad R; Krämer A; Schild HH
    Rofo; 2001 May; 173(5):424-9. PubMed ID: 11414150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
    Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
    Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases.
    Rapaccini GL; Pompili M; Caturelli E; Anti M; Aliotta A; Cedrone A; Amadei E; Grattagliano A; Squillante MM; Rabitti C
    Dig Dis Sci; 1990 Apr; 35(4):422-7. PubMed ID: 1690630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in cirrhotic liver in Trieste.
    Melato M; Valente M; Mucli E; Muuse MM; Taraglio S
    J Gastroenterol Hepatol; 1989; 4(6):521-7. PubMed ID: 2562353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
    Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors.
    Bröker ME; Ijzermans JN; Witjes CD; van Vuuren HJ; de Man RA
    PLoS One; 2014; 9(7):e100187. PubMed ID: 25033446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
    Elzouki AN; Eriksson S
    Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.
    Makol A; Kanthaje S; Dhiman RK; Kalra N; Chawla YK; Chakraborti A
    Exp Biol Med (Maywood); 2018 Feb; 243(4):323-326. PubMed ID: 29186978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
    van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
    Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
    Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma.
    Garrido A; Djouder N
    Trends Cancer; 2021 Jan; 7(1):29-36. PubMed ID: 32917550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
    Kim MJ; Lee S; An C
    Eur Radiol; 2019 Sep; 29(9):5101-5110. PubMed ID: 30788586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of contrast enhanced ultrasound (CEUS) of hepatocellular carcinoma in patients with cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS).
    Chang J; Dumitrache A; Böhling N; Abu-Omar J; Meyer C; Strobel D; Luetkens J; Luu AM; Rockstroh J; Strassburg CP; Trebicka J; Gonzalez-Carmona MA; Marinova M; Praktiknjo M
    Sci Rep; 2020 Nov; 10(1):20682. PubMed ID: 33244180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
    BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for hepatocellular carcinoma in cirrhosis.
    Bolondi L
    J Hepatol; 2003 Dec; 39(6):1076-84. PubMed ID: 14642630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.